AMA delegation chair Gary L. Bryant, MD, outlines AMA’s progress with ongoing initiatives, new resolutions submitted by the ACR
Advocate for Rheumatology Issues During Election Season
The ACR encourages members to meet with elected officials during Congress’ fall recess
Rheumatology Outreach in Macedonia
Occupational therapist Carole Dodge, OT, CHT, describes experience providing hand therapy to patients with arthritis, rheumatic disease
Accelerating Medicines Partnership Targets Therapies for Rheumatoid Arthritis, Systemic Lupus Erythematosus
Research collaboration among scientists, pharmaceutical companies, nonprofits promotes precompetitive sharing of data collection, analyses
Funding Crisis Threatens Research and Training in Rheumatology
The ACR and Rheumatology Research Foundation present data to reinforce importance of supporting rheumatology research
Omnibus Rule Compliance Deadline Imminent
Business associate agreements under pressure to meet new, expanded HIPAA standards by September 23
The ACR’s Advocates for Arthritis Volunteers Meet with Congress
Access to rheumatology patient care, treatment, research funding on the agenda
RheumPAC: The Voice of the ACR
How the ACR’s political action committee represents interests of rheumatologists, patients with Congressional lawmakers
Update on Legislation, Advocacy Efforts to Advance Rheumatology
Status of progess to fix sustainable growth rate physician formula, other rheumatology-related issues facing Congress
The ACR Testifies before Congress on Patient Access
The ACR’s Government Affairs Committee chair Will Harvey, MD, brings lawmakers’ attention to Patients’ Access to Treatments Act, problem of specialty drug tiers, excessive cost sharing for patients
- « Previous Page
- 1
- …
- 61
- 62
- 63
- 64
- 65
- …
- 86
- Next Page »